PPARGC1A and Alzheimer disease: Using the 2×Tg-AD mouse line, combined with AAV-Ppargc1α microinjection, we successfully forced PGC-1α overexpression in the LPtA of AD brain, as indicated by the strong expression of HA-labeled PGC-1α.